TransactIQ

Professional M&A Intelligence

Transform SEC filings into actionable deal intelligence

Professional-grade AI that extracts key terms, identifies risks, and answers your questions about SEC filings in seconds. Ask questions in natural language and get instant answers with citations. Trusted by investment banks, law firms, and hedge funds.

Important: All analysis and content is for informational purposes only and does not constitute investment advice. AI-generated summaries may contain inaccuracies and should be independently verified before making decisions.

Enterprise Security
Trusted Platform
High Availability

Free 7-day trial • No credit card required • Enterprise security

Speed

<30s

Analysis Time

Accuracy

99.7%

Precision Rate

Coverage

50+

Metrics Extracted

Interactive Q&A

Ask questions in natural language and get instant answers with page-specific citations.

Enterprise Security

Bank-grade encryption, secure infrastructure, and comprehensive audit trails for sensitive data.

Live
Real-time Updates
Trusted by 500+ Analysts
Trusted by Industry Leaders

The numbers speak for themselves

Join hundreds of investment professionals who rely on TransactIQ for their most critical deal analysis.

500+
Investment Professionals
99.7%
Analysis Accuracy
50+
Fortune 500 Companies
Enterprise
Security Grade

What our clients say

Don't just take our word for it

"TransactIQ has revolutionized how we analyze deals. What used to take hours now takes minutes, and the accuracy is remarkable."

SC
Sarah Chen
Senior M&A Analyst
Top Investment Bank

"The citation system gives us complete confidence in every claim. It's like having a legal team review every document instantly."

MR
Michael Rodriguez
Partner
Leading Law Firm

"We've increased our deal analysis capacity by 300% while maintaining the highest quality standards. Game-changing technology."

JK
Jennifer Kim
Head of Research
Major Hedge Fund
Professional-Grade Features

Everything you need for deal analysis

Built by M&A professionals for M&A professionals. Every feature designed to eliminate ambiguity and accelerate your workflow.

AI-Powered

Interactive Q&A

Ask questions in natural language about any filing and get instant, AI-powered answers with page-specific citations and confidence scores. Perfect for due diligence and deal analysis.

99.7% Accuracy

AI-Powered Analysis

Advanced NLP extracts key deal terms, risk factors, and financial metrics from complex SEC filings with 99.7% accuracy.

100% Traceable

Citation Verification

Every claim is linked to its source document with page references and confidence scores for complete transparency.

< 30 Seconds

Real-Time Processing

Analyze filings in seconds, not hours. Get instant alerts on new deals and regulatory updates.

Enterprise Grade

Enterprise Security

Bank-grade encryption, secure cloud infrastructure, role-based access controls, and comprehensive audit trails for sensitive deal data.

50+ Metrics

Deal Intelligence

Extract CVR terms, break-up fees, regulatory timelines, and complex consideration structures automatically.

Unlimited Tickers

Portfolio Monitoring

Track multiple deals simultaneously with custom alerts, risk scoring, and performance analytics.

Transform your M&A workflow

Ask questions in natural language
Reduce analysis time by 90%
Eliminate manual document review
Catch critical deal terms instantly
Stay ahead of regulatory changes
Scale across unlimited deals
Latest Intelligence

Deal Intelligence from ArbitrageEdge

Executive-grade analysis on the latest M&A activity, deal structures, and market-moving transactions.

View All Insights
Cover image for Kimberly-Clark Buys Kenvue: The $48 Billion Bet to Build a “Global Health & Wellness Engine”

When Kimberly-Clark (NYSE: KMB) announced its plan to acquire Kenvue (NYSE: KVUE) on November 3, 2025, the market didn&#8217;t flinch &#8212; but it should have.

Nov 4, 2025
ArbitrageEdge
Cover image for Top 5 Risk Arbitrage Setups

1) Electronic Arts (EA) &#8594; PIF / Silver Lake / Affinity (All-Cash, $210)

Nov 2, 2025
ArbitrageEdge
Cover image for Pfizer vs. Novo Nordisk: The First Major Antitrust Battle of the Obesity-Drug Arms Race

The Setup: Pfizer&#8217;s Bid for Metsera

Nov 2, 2025
ArbitrageEdge

Stay ahead of the deal flow with executive-grade analysis

Explore All Insights
🚀

Partnerships & Investment

We're a lean, ambitious team building the future of M&A intelligence. If you're interested in strategic partnerships or investment opportunities, we'd love to hear from you.

Fast-Growing

Serving institutional investors and M&A professionals

Proven Tech

Advanced AI, robust infrastructure, enterprise-ready

Scalable Vision

Clear roadmap for expansion and growth

Interested in discussing partnerships, strategic alliances, or investment?

💼Schedule a Conversation
Ready to Transform Your Analysis?

Start analyzing deals like a pro

Join 500+ investment professionals who rely on TransactIQ for their most critical deal analysis. Start with a free trial today.

7-day free trial
No credit card required
Enterprise security

Stay Ahead of the Market

Get weekly M&A insights and deal intelligence from our research team

Stay updated with ArbitrageEdge

Get the latest deal insights delivered to your inbox

Subscribe

Lightning Fast

Analyze complex filings in under 30 seconds with our advanced AI

Enterprise Security

Bank-grade encryption and secure infrastructure for sensitive deal data

Real-Time Monitoring

Get instant alerts on new deals and regulatory updates